Yayıncı "Amer Assoc Cancer Research" için listeleme
Toplam kayıt 10, listelenen: 1-10
-
A Role for Endothelin-2 and Its Receptors in Breast Tumor Cell Invasion
(Amer Assoc Cancer Research, 2004)We have studied the role of endothelins (ET-1, ET-2 and ET-3) and ET receptors (ET-RA and ET-RB) in the invasive capacity of breast tumor cells, which express ET-I and ET-2 as well as ET-RA and ET-RB. Of five human breast ... -
Antiadhesive Effects of Grn163L - An Oligonucleotide N3 '-> P5 ' Thio-Phosphoramidate Targeting Telomerase
(Amer Assoc Cancer Research, 2007)We determined previously that a novel human telomerase RNA (hTR) antagonist, GRN163L, inhibited the tumorigenic potential of A549-luciferase (A549-luc) lung cancer cells in vitro and in vivo. Further studies revealed that ... -
Genetic Predisposition To Fiber Carcinogenesis Causes A Mesothelioma Epidemic In Turkey
(Amer Assoc Cancer Research, 2006)Malignant mesothelioma in the western world is often associated with asbestos exposure. It is a relatively rare cancer that causes similar to 2,500 deaths yearly in the United States and 1,000 deaths yearly in the United ... -
In Vivo Inhibition Of Lung Cancer By Grn163L: A Novel Human Telomerase Inhibitor
(Amer Assoc Cancer Research, 2005)Differential regulation of telomerase activity in normal and tumor cells provides a rationale for the design of new classes of telomerase inhibitors. The telomerase enzyme complex presents multiple potential sites for the ... -
Induction Of Telomere Dysfunction Mediated By The Telomerase Substrate Precursor 6-Thio-2'-Deoxyguanosine
(Amer Assoc Cancer Research, 2015)The relationships between telomerase and telomeres represent attractive targets for new anticancer agents. Here, we report that the nucleoside analogue 6-thio-2'-deoxyguanosine (6-thio-dG) is recognized by telomerase and ... -
Rational Drug Redesign to Overcome Drug Resistance in Cancer Therapy: Imatinib Moving Target
(Amer Assoc Cancer Research, 2007)Protein kinases are central targets for drug-based cancer treatment. To avoid functional impairment, the cell develops mechanisms of drug resistance, primarily based on adaptive mutations. Redesigning a drug to target a ... -
Reactivation of Camp Pathway by Pde4D Inhibition Represents A Novel Druggable Axis for Overcoming Tamoxifen Resistance in Er-Positive Breast Cancer
(Amer Assoc Cancer Research, 2018)Purpose: Tamoxifen remains an important hormonal therapy for ER-positive breast cancer; however, development of resistance is a major obstacle in clinics. Here, we aimed to identify novel mechanisms of tamoxifen resistance ... -
Sustained Adrenergic Signaling Promotes Intratumoral Innervation Through Bdnf Induction
(Amer Assoc Cancer Research, 2018)Mounting clinical and preclinical evidence supports a key role for sustained adrenergic signaling in the tumor microenvironment as a driver of tumor growth and progression. However, the mechanisms by which adrenergic ... -
The Inflammatory Cytokine Tumor Necrosis Factor-Alpha Generates An Autocrine Tumor-Promoting Network In Epithelial Ovarian Cancer Cells
(Amer Assoc Cancer Research, 2007)Constitutive expression of the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) is characteristic of malignant ovarian surface epithelium. We investigated the hypothesis that this autocrine action of TNF-alpha ... -
Wwox And Ap2 Gamma Expression Levels Predict Tamoxifen Response
(Amer Assoc Cancer Research, 2007)Purpose: Assessment of expression levels of Wwox, Wwox- interacting proteins Ap2 alpha, Ap2 gamma, and ErbB4, the Ap2 gamma transcriptional target protein Her2, and the possible Ap2 alpha transcriptional target Prka Rl ...